Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Preventive Cardio-Oncology: The Time Has Come
Sherry‐Ann Brown
Frontiers in Cardiovascular Medicine (2020) Vol. 6
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Cardiotoxicity of Anthracyclines
Daniela Cardinale, Iacopo Fabiani, Carlo M. Cipolla
Frontiers in Cardiovascular Medicine (2020) Vol. 7
Open Access | Times Cited: 329
Pragmatic randomised clinical trial of proton versus photon therapy for patients with non-metastatic breast cancer: the Radiotherapy Comparative Effectiveness (RadComp) Consortium trial protocol
Justin E. Bekelman, Hien L. Lu, Stephanie L. Pugh, et al.
BMJ Open (2019) Vol. 9, Iss. 10, pp. e025556-e025556
Open Access | Times Cited: 93
Complications and comorbidities associated with antineoplastic chemotherapy: Rethinking drug design and delivery for anticancer therapy
Xiaoman Mao, Shuang Wu, Dandan Huang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2901-2926
Open Access | Times Cited: 8
[Cardiotoxicity of anthracycline].
Daniela Cardinale, Iacopo Fabiani, Carlo M. Cipolla
PubMed (2000) Vol. 54, Iss. 4, pp. 467-85
Open Access | Times Cited: 188
A new classification of cardio-oncology syndromes
Rudolf A. de Boer, Joseph Pierre Aboumsallem, Valentina Bračun, et al.
Cardio-Oncology (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 54
Cardiovascular Biomarkers in Cardio-Oncology: Antineoplastic Drug Cardiotoxicity and Beyond
Umberto Attanasio, Elena Di Sarro, Lucia Tricarico, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 199-199
Open Access | Times Cited: 6
Real-world treatment patterns and adverse events in metastatic renal cell carcinoma from a large US claims database
Sumanta K. Pal, Jun Gong, Shivani K. Mhatre, et al.
BMC Cancer (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 41
A virtual-hybrid approach to launching a cardio-oncology clinic during a pandemic
Sherry‐Ann Brown, Sahishnu Patel, David Rayan, et al.
Cardio-Oncology (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 24
Neighborhood Archetypes and Cardiovascular Health in Black Breast Cancer Survivors
Carola T. Sánchez-Díaz, Riddhi A. Babel, Hari S. Iyer, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 3, pp. 405-418
Open Access | Times Cited: 3
Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals
Irma Bisceglia, Maria Laura Canale, Nicola Silvestris, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 8
Cardio-Oncology Health Disparities: Social Determinants of Health and Care for Black Breast Cancer Survivors
Lakeshia Cousin, Natalee Roper, Timiya S. Nolan
Clinical journal of oncology nursing (2021) Vol. 25, Iss. 5, pp. 36-41
Open Access | Times Cited: 18
Novel molecular biomarkers of cancer therapy‐induced cardiotoxicity in adult population: a scoping review
Irene Cartas Espinel, Marcelino Telechea‐Fernández, Carlos Manterola, et al.
ESC Heart Failure (2022) Vol. 9, Iss. 3, pp. 1651-1665
Open Access | Times Cited: 13
The role of digital health in the cardiovascular learning healthcare system
Ragasnehith Maddula, James MacLeod, Tyson McLeish, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 13
#CardioOncology: Twitter chat as a mechanism for increasing awareness of heart health for cancer patients
Claire C. Conley, Neha Goyal, Sherry‐Ann Brown
Cardio-Oncology (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 15
Next Generation Risk Markers in Preventive Cardio-oncology
Morgan Lamberg, Andrea Rossman, Alexandra Bennett, et al.
Current Atherosclerosis Reports (2022) Vol. 24, Iss. 6, pp. 443-456
Open Access | Times Cited: 8
Cardiovascular Risk Assessment and Prevention in Cardio-Oncology
Omar Mohamed Makram, Priyanshu Nain, Alexi Vasbinder, et al.
Cardiology Clinics (2024) Vol. 43, Iss. 1, pp. 1-11
Closed Access | Times Cited: 1
Exercise, cancer and cardiovascular disease: what should clinicians advise?
Allison Zimmerman, Maria Isabel Camara Planek, Catherine Chu, et al.
Cardiovascular Endocrinology & Metabolism (2020) Vol. 10, Iss. 2, pp. 62-71
Open Access | Times Cited: 10
Cardiovascular Risks in Testicular Cancer: Assessment, Prevention, and Treatment
Suparna C. Clasen, Chunkit Fung, Howard D. Sesso, et al.
Current Oncology Reports (2023) Vol. 25, Iss. 5, pp. 445-454
Closed Access | Times Cited: 3
Advancing the care of individuals with cancer through innovation & technology: Proceedings from the cardiology oncology innovation summit 2020 and 2021
Sherry‐Ann Brown, Craig J. Beavers, Brenton Bauer, et al.
American Heart Journal Plus Cardiology Research and Practice (2023) Vol. 38, pp. 100354-100354
Open Access | Times Cited: 3
Preventive Cardio-Oncology: Cardiovascular Disease Prevention in Cancer Patients and Survivors
Iacopo Fabiani, Mary Branch, Daniela Cardinale, et al.
Current Treatment Options in Cardiovascular Medicine (2021) Vol. 23, Iss. 1
Closed Access | Times Cited: 8
The Importance of Primary Care in Cardio-Oncology
D. Cehic, Aaron L. Sverdlov, Bogda Koczwara, et al.
Current Treatment Options in Oncology (2021) Vol. 22, Iss. 12
Closed Access | Times Cited: 8
Perceptions of the Cardiologists and Oncologists: Initial Step for Establishing Cardio-Oncology Service
Hasan Ali Farhan, Israa Fadhil Yaseen
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 8
Pandemic Perspective: Commonalities Between COVID-19 and Cardio-Oncology
Sherry‐Ann Brown, Svetlana Zaharova, Peter Mason, et al.
Frontiers in Cardiovascular Medicine (2020) Vol. 7
Open Access | Times Cited: 5
Modeling Precision Cardio-Oncology: Using Human-Induced Pluripotent Stem Cells for Risk Stratification and Prevention
Tatiana R. Perry, Michelle L. Roberts, Bipin Sunkara, et al.
Current Oncology Reports (2021) Vol. 23, Iss. 7
Open Access | Times Cited: 5
Radiation-Induced Cardiotoxicity
Samuel J. Zorn, David Rayan, Sherry‐Ann Brown, et al.
Advances in Oncology (2021) Vol. 1, pp. 1-13
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top